EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE® (TrenibotE)

Yingchao Yang iD, Huajie Zhang, Shuo Wang, Yanhua Xue, Liyong Yuan

Toxins · 2025

DOI: 10.3390/toxins18010019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Yingchao Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes for Food and Drug Control, Beijing 102629, China. Hauptthemen laut MEDLINE: Botulinum Toxins. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

As an innovative drug derived from botulinum neurotoxin serotype E, TrenibotulinumtoxinE® demonstrates a rapid onset and shorter effect. Due to concerns regarding specificity, test throughput, and animal welfare, a new cell-based potency assay (CBPA) method was developed for BoNT/E drug substance and drug product; independent evaluation of this new CBPA was required. (2)

Methods

The CBPA for BoNT/E is a quantitative assay that measures the accumulated cleaved SNAP25180 in human neuroblastoma cells. It involves sequential culturing, differentiation of cells, and then treatment with drug products. Data were analyzed using a quadratic parallel model via statistical software. Linearity was determined using five effective concentration levels. Key assay parameters including accuracy, linearity, repeatability, intermediate precision and range were evaluated. (3)

Results

The overall assay’s accuracy was 98%, and the intermediate precision was 6.3%. The coefficient of determination (R2) and slope were determined as 0.963 and 0.942, respectively. The root mean squared error (RMSE) was 0.057, and the intercept was 0.032 for the combined data. The repeatability was 2.4%, which is well within the acceptance criterion of ≤8%. (4)

Conclusions

The evaluation was carried out within a single laboratory under controlled conditions; the new CBPA meets all acceptance criteria and can be used for BoNT/E potency determination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsHumansCell Line, TumorBiological AssayReproducibility of ResultsSynaptosomal-Associated Protein 25

Stichwörter der Autor:innen

CBPASNAP25180botulinum toxin type E

Substanzen

Botulinum Toxinsbotulinum toxin type ESynaptosomal-Associated Protein 25

Autor:innen und Institutionen

  • National Institutes for Food and Drug Control, Beijing 102629, China.

ORCID-Profile: Yingchao Yang

Zitieren

APA

Yang, Y., Zhang, H., Wang, S., Xue, Y., & Yuan, L. (2025). Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE® (TrenibotE). Toxins. https://doi.org/10.3390/toxins18010019

Vancouver

Yang Y, Zhang H, Wang S, Xue Y, Yuan L. Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE® (TrenibotE). Toxins. 2025. doi:10.3390/toxins18010019

BibTeX
@article{Yang2025,
  author = {Yang, Yingchao and Zhang, Huajie and Wang, Shuo and Xue, Yanhua and Yuan, Liyong},
  title = {Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE® (TrenibotE)},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins18010019}
}
Kostenlos starten →